help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 44, No. 5 939-946
doi:10.1210/jcem-44-5-939
Copyright © 1977 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BACHELOT, I.
Right arrow Articles by ODELL, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BACHELOT, I.
Right arrow Articles by ODELL, W. D.

Pituitary and Plasma Lipotropins: Demonstration of the Artifactual Nature of βMSH

IVAN BACHELOT*, ADA R. WOLFSEN and WILLIAM D. ODELL

Departments of Medicine and Physiology, Harbor General Hospital Torrance, California

Evidence has been presented by others that βSMSH immunoreactivity in human plasma is due to β and {gamma} lipotropin rather than βMSH. We have studied this question in normal subjects utilizing a sensitive human /3MSH radioimmunoassay capable of quantifying βMSH in unextracted plasma with a sensitivity of 7.5 pg/ml. Purified human /3 lipotropin cross-reacted 30% on a molar basis with synthetic human βMSH in this assay. ACTH related peptides showed <0.1% cross-reactivity. Normal values at 0800 h were 19.6±2.4 pg/ml and suppressed to 9.3±1.3 pg/ml following dexamethasone. Metyrapone increased 0800 h values to 379.6±89.9 pg/ml. Chromatographic studies on Sephadex G-50 demonstrated no /3MSH per se in human pituitaries, plasma from metyrapone treated normals, patients with Cushing's disease, Nelson's syndrome, or Addison's disease. βMSH immunoreactivity showed the elution pattern of βlipotropin.

* Present address: Ivan Bachelot, M.D., C.H.U. de Grenoble, 38.700 La Tronche, France.

Supported by NCI Contract No. NOI-CB-43903. Dr. Bachelot was supported by the Council for Int'l Exch. of Persons (Sr. Fulbright-Hays Program Travel Grant

These studies were presented at the Western section of the American Federation for Clinical Research, Feb. 1976, Carmel, California.

Received August 9, 1977.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
E. M. GOLD
The Cushing Syndromes: Changing Views of Diagnosis and Treatment
Ann Intern Med, May 1, 1979; 90(5): 829 - 844.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society